Nicole Crawford
Family · Easley, SCNPI 1376197335
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 907 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 41 manufacturers reported payments, led by AstraZeneca at 33.3% of the total. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 907 payments — averaging $23.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$7K
- GSK$3K
- Boehringer Ingelheim$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Amgen$999
- Sanofi$928
- plus $7K from 35 others
What the payments were for
- Food & beverage$21,187100%
- Education$450%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$2,065
- BREZTRI$1,979
- FASENRA$1,732
- AIRSUPRA$1,121
- SYMBICORT$723
- DUPIXENT$572
- BEVESPI AEROSPHERE$502
- FARXIGA$243
- TRELEGY ELLIPTA$223
- FREESTYLE LIBRE 3$148
- ABRYSVO$124
- NUCALA$124
- Wegovy$124
- ACTHAR$123
- Repatha$122
- Kerendia$122
- XOLAIR$118
- VIVITROL$116
- PREVNAR 20$104
How this compares
$21,232 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 773 | $556,129 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 344 | $267,002 |
| WakixPitolisant Hcl | 16 | $213,631 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 75 | $47,110 |
| Breo ElliptaFluticasone/Vilanterol | 96 | $44,886 |
| Spiriva RespimatTiotropium Bromide | 69 | $44,044 |
| SymbicortBudesonide/Formoterol Fumarate | 132 | $36,370 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 803 | $23,913 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 100 | $17,191 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $10,807 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $9,373 |
| BreynaBudesonide/Formoterol Fumarate | 49 | $9,016 |
| Levocetirizine Dihydrochloride | 443 | $7,404 |
| Wixela InhubFluticasone Propion/Salmeterol | 83 | $6,778 |
| Montelukast Sodium | 818 | $6,530 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $3,072 | $610,387885 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $7,078 | $303,372476 claims |
| Harmony Biosciences LLCWakix | $231 | $213,63116 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $1,514 | $91,154144 claims |
| PfizerEliquis | $228 | $4,33611 claims |
| Covis Pharma GmbHAlvesco | $116 | $4,16414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.
Other family in Easley
- Jessica BellEasley$96K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
- Hailey AtkinsonIrmo$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.